{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:31:58Z","timestamp":1792740718797,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e24742","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T19:50:13Z","timestamp":1706125813000},"page":"e24742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease"],"prefix":"10.1016","volume":"10","author":[{"given":"Wenjun","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-3359","authenticated-orcid":false,"given":"Jingguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8108-9013","authenticated-orcid":false,"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e24742_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib2","first-page":"86","article-title":"Chinese expert consensus on the diagnosis and treatment of diseases associated with anti-myelin oligodendrocyte glycoprotein immunoglobulin G antibodies","volume":"27","author":"Wei","year":"2002","journal-title":"J. Neuroimmunol. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e24742_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000235944","article-title":"The discovery of oligoclonal bands: a 50-year anniversary","volume":"62","author":"Holm\u00f8y","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib6","first-page":"86","article-title":"Detection of oligoclonal ig bands: clinical significance and trends in methodological improvement","volume":"15","author":"Trbojevic-Cepe","year":"2004","journal-title":"Ejifcc"},{"key":"10.1016\/j.heliyon.2024.e24742_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0009-8981(64)90136-6","article-title":"Immunological comparison of some proteins found in cerebrospinal fluid, urine and extracts from brain and kidney","volume":"10","author":"Laterre","year":"1964","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"10.1016\/j.heliyon.2024.e24742_bib8","first-page":"2465","article-title":"Establishment and consistency verification of the standard operation procedure for laboratory detection of immunoglobulin G oligoclonal bands in cerebrospinal fluid","volume":"101","author":"Liu","year":"2021","journal-title":"Natl. Med. J. China (Peking)"},{"issue":"Pt 5","key":"10.1016\/j.heliyon.2024.e24742_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/brain\/113.5.1269","article-title":"A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications","volume":"113","author":"McLean","year":"1990","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib11","article-title":"Paraneoplastic AQP4-IgG-seropositive neuromyelitis optica spectrum disorder associated with teratoma: a case report and literature review","volume":"8","author":"Ikeguchi","year":"2021","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e24742_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WCO.0000000000000328","article-title":"Demyelinating diseases in asia","volume":"29","author":"Ochi","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib13","first-page":"898","article-title":"Analysis of clinical characteristics of patients with anti-myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor antibody positive","volume":"54","author":"Shen","year":"2021","journal-title":"Chin. J. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","article-title":"Autoimmune encephalitis: clinical spectrum and management","volume":"21","author":"Uy","year":"2021","journal-title":"Practical Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jclinpath-2021-207766","article-title":"Diagnostic significance of IgG and albumin indices versus oligoclonal band types in demyelinating disorders","volume":"76","author":"Belimezi","year":"2023","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/jnnp-2020-325868","article-title":"Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies","volume":"92","author":"Ruiz","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e24742_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12987-020-00196-2","article-title":"Choroid plexus and the blood-cerebrospinal fluid barrier in disease","volume":"17","author":"Sol\u00e1r","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.heliyon.2024.e24742_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.heliyon.2024.e24742_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1756285611433772","article-title":"Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more","volume":"5","author":"Mayer","year":"2012","journal-title":"Therapeutic advances in neurological disorders"},{"key":"10.1016\/j.heliyon.2024.e24742_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675307","article-title":"Cerebrospinal fluid findings in 541 patients with clinically isolated syndrome and multiple sclerosis: a monocentric study","volume":"12","author":"Berek","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e24742_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.heliyon.2024.e24742_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e24742_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646940","article-title":"Longitudinal CSF findings in autoimmune encephalitis-A monocentric cohort study","volume":"12","author":"Zrzavy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(83)91075-6","article-title":"Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction","volume":"74","author":"Winfield","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2024.e24742_bib28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/1352458511431729","article-title":"The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude","volume":"18","author":"Lechner-Scott","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.heliyon.2024.e24742_bib29","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1093\/brain\/awad122","article-title":"Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids","volume":"146","author":"Matsumoto","year":"2023","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib31","doi-asserted-by":"crossref","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","article-title":"Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies","volume":"94","author":"Martinez-Hernandez","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2024.e24742_bib32","article-title":"Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability","volume":"9","author":"Kwon","year":"2022","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e24742_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e24742_bib34","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1212\/WNL.0000000000201662","article-title":"Significance of myelin oligodendrocyte glycoprotein antibodies in CSF: a retrospective multicenter study","volume":"100","author":"Carta","year":"2023","journal-title":"Neurology"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:22:04Z","timestamp":1769044924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024007734"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24742","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24742"}}